KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Finished Goods: 2017-2018

  • BeOne Medicines' Finished Goods was N/A to $6.3 million in Q2 2018 from the same period last year, while for Jun 2018 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $10.9 million for FY2017, which is N/A change from last year.
  • Latest data reveals that BeOne Medicines reported Finished Goods of $6.3 million as of Q2 2018, which was down 15.68% from $7.5 million recorded in Q1 2018.
  • In the past 5 years, BeOne Medicines' Finished Goods registered a high of $10.9 million during Q4 2017, and its lowest value of $5.7 million during Q3 2017.
  • Over the past 2 years, BeOne Medicines' median Finished Goods value was $6.9 million (recorded in 2018), while the average stood at $7.6 million.